CONMED shares gained 0.8% to close at $95.60 on Wednesday. These analysts made changes to their price targets on CONMED after the company reported quarterly results. Needham increased the price ...

Conmed (CNMD) delivered earnings and revenue surprises of 6.76% and 1.70%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

CONMED (CNMD) acquires privately-held Biorez, Inc. for $85 million. The deal is set to boost CONMED's sports medicine portfolio with the addition of Biorez's proprietary BioBrace Implant technology.

CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately held Biorez, Inc. (Biorez), on a cash-free, debt-free basi ...

Conmed's shares dropped 30% on competition worries, but growth drivers like AirSeal and BioBrace support fair value close to $100. Learn more on CNMD stock here.

We think that Stryker Corporation currently is a better bet compared to Conmed Corp. CNMD stock trades at 4x trailing revenues, lower than that of SYK, whose P/S multiple stands at 6.1x. Does this ...

Shares of this Zacks Rank #3 (Hold) company have lost 22.7% so far this year against the industry’s 0.6% gain. The S&P 500 Index has increased 5.2% in the same time frame.

CONMED Corporation (NASDAQ:CNMD) today announced a definitive agreement to acquire privately-held Buffalo Filter LLC (Buffalo Filter) for $365 million ...

Looking at stock returns, ConMed’s -19% return is comparatively better than DENTSPLY’s -45% change over the last twelve months. This compares with a -3% change in the broader S&P 500 index.

Stifel has downgraded CONMED (NYSE:CNMD) to hold from buy citing Q1 hospital purchasing data on Airseal disposables as a key factor. The investment bank also cut its price target to $55 from $75 ...

Conmed said it sees FY2025 adjusted EPS of $4.25-4.40, versus market estimates of $4.74. The company expects sales of $1.344 billion-1.372 billion, versus projections of $1.40 billion.